Xenotransplantation is the transplantation of organs or cells from a non-human animal into a human. [ + ]

When the immune system identifies a cell that needs to be eliminated, such as a virus-infected cell or cancer cell, natural killer cells descend and puncture the offending cell, injecting toxic enzymes to spell its doom. [ + ]

The S&P/ASX 200 Healthcare Index ended the month down on Friday closing at 8179.3 points compared to the 8202.1 point close on October 1, indicating that investors remain cautious about the sector. [ + ]

This year’s $400,000 Victorian Cancer Agency (VCA) Clinical Fellowship has been awarded to Dr Clare Scott from theWalter and Eliza Hall Institute (WEHI) to help advance her ground-breaking work on epithelial ovarian cancer. [ + ]

PricewaterhouseCoopers has released its Q1FY11 BioForum report on Australia’s life sciences and biotech equities, revealing that the sector went backwards slightly as the wider market advanced. [ + ]

The first pilot phase of the 1000 Genomes Project has now ended with the results published this week in the journal Nature (doi:10.1038/nature09534). [ + ]

Living Cell Technologies (LCT), the Australian biotech developing a porcine-based cell implant to combat diabetes, today reported that 10 of the 12 insulin-dependent diabetes patients taking part in the clinical trial of its Diabecell product in New Zealand have shown marked improvement. [ + ]

Australians continue to strongly support biotechnologies that provide health and environmental benefits, but support for genetically modified (GM) foods has dropped slightly since 2007, a new survey has found.

Researchers from Sydney's Garvan Institute of Medical Research have uncovered a mechanism by which immune cells interact, giving insight into the causes of Type 1 diabetes, where the body's own immune cells target the insulin-producing beta cells in the pancreas. [ + ]

IRL Chief Executive Shaun Coffey has applauded the introduction of the technology transfer voucher funding scheme announced recently by the government but says the country as a whole can do more.

Melbourne biotech Hatchtech announced today that it has raised $6.3 million to fund Phase IIb clinical trials for its novel treatment for head lice. [ + ]

A national survey to gauge how Australians feel about biotechnology has shown that the majority are strongly supportive of those efforts which lead to health and environmental benefits, while support for genetically modified (GM) food has fallen amid ongoing confusion and uncertainty. [ + ]

The treatment of a range of human blood cancers, such as chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia, may be improved as a result of international research involving The University of Western Australia.

IRL has been selected as one of six accredited research organisations for the first phase of the government-funded technology transfer voucher funding scheme.

Australian Proteome Analysis Facility (APAF), Macquarie University and Agilent Technologies Australia have announced a joint research collaboration in the field of glycoproteomics, to be led by Professor Nicolle Packer.